The action of calcium antagonists in the human natural killer cell-mediated cytotoxicity. 1987

K Waschke, and R von Baehr, and G Wolf

The Ca2+-channel blocker Nifedipine and the Calmodulin inhibitor Prothazin suppressed the human NK-mediated cytolysis. Both drugs exerted the same dose-dependent effect. The inhibition was partially reversible after withdrawing of the Ca2+-antagonists. There exists evidence that neither effector-target cell binding, nor effector cell function, but the initiation of the target cell lysis was affected by these inhibitors. Hence, the Ca2+-requirement of the NK cytotoxic reaction seems to be due to an essential Ca2+-influx into the target cell.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011398 Promethazine A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals. Proazamine,Atosil,Diphergan,Diprazin,Isopromethazine,Phenargan,Phenergan,Phensedyl,Pipolfen,Pipolphen,Promet,Prometazin,Promethazine Hydrochloride,Prothazin,Pyrethia,Remsed,Rumergan,Hydrochloride, Promethazine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Waschke, and R von Baehr, and G Wolf
May 1987, Cellular immunology,
K Waschke, and R von Baehr, and G Wolf
January 1988, Annals of the New York Academy of Sciences,
K Waschke, and R von Baehr, and G Wolf
October 1996, Bone marrow transplantation,
K Waschke, and R von Baehr, and G Wolf
May 1984, Clinical and experimental immunology,
K Waschke, and R von Baehr, and G Wolf
January 1991, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
K Waschke, and R von Baehr, and G Wolf
March 1982, Journal of immunology (Baltimore, Md. : 1950),
K Waschke, and R von Baehr, and G Wolf
January 1987, Advances in experimental medicine and biology,
K Waschke, and R von Baehr, and G Wolf
June 2019, Journal of leukocyte biology,
K Waschke, and R von Baehr, and G Wolf
January 1999, Cell transplantation,
K Waschke, and R von Baehr, and G Wolf
May 2002, European journal of biochemistry,
Copied contents to your clipboard!